bpc 157 reduces fibrosis Stable Gastric Pentadecapeptide 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions BPC-157 Explained: What We Know
Description
Ayotte, D
The tricky part is that mild degradation produces no visible changes
Individual responses vary, but some individuals may experience improvements in energy levels and symptoms within a few days after starting B12 injections.
Grozdev 2014
Dilution itself doesn't degrade the peptide
